The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kaldyrkaeva O.S.

National Medical Research Centre of Cardiology named after academician E.I. Chazov

Arzamastsev E.V.

National Medical Research Centre of Cardiology named after academician E.I. Chazov

Terekhova O.A.

National Medical Research Centre of Cardiology named after academician E.I. Chazov

Afanasieva E.Yu.

National Medical Research Centre of Cardiology named after academician E.I. Chazov

Levitskaya E.L.

National Medical Research Centre of Cardiology named after academician E.I. Chazov

Kydryavtseva E.V.

National Medical Research Centre of Cardiology named after academician E.I. Chazov

Polyektova V.P.

National Medical Research Centre of Cardiology named after academician E.I. Chazov

Gaisinyuk T.V.

National Medical Research Centre of Cardiology named after academician E.I. Chazov

Borisova E.Ya.

MIREA — Russian Technological University

Borisova N.Yu.

MIREA — Russian Technological University

Asilova N.Yu.

MIREA — Russian Technological University

Zubin E.M.

MIREA — Russian Technological University

Krylov A.V.

MIREA — Russian Technological University

Antiarrhythmic properties and toxicological characteristics of N-(2-(2-(dialkylamino)ethoxy)ethyl)carboxamides

Authors:

Kaldyrkaeva O.S., Arzamastsev E.V., Terekhova O.A., Afanasieva E.Yu., Levitskaya E.L., Kydryavtseva E.V., Polyektova V.P., Gaisinyuk T.V., Borisova E.Ya., Borisova N.Yu., Asilova N.Yu., Zubin E.M., Krylov A.V.

More about the authors

Journal: Russian Cardiology Bulletin. 2022;17(2): 47‑54

DOI: 10.17116/Cardiobulletin20221702147

Read: 1249 times

Download PDF (RU)
Contact the author
Table of contents

ANTIARRHYTHMIC PROPERTIES AND TOXICOLOGICAL CHARACTERISTICS OF N-(2-(2-(DIALKYLAMINO)ETHOXY)ETHYL)CARBOXAMIDES
ANTIARRHYTHMIC PROPERTIES AND TOXICOLOGICAL CHARACTERISTICS OF N-(2-(2-(DIALKYLAMINO)ETHOXY)ETHYL)CARBOXAMIDES

To cite this article:

Kaldyrkaeva OS, Arzamastsev EV, Terekhova OA, et al. . Antiarrhythmic properties and toxicological characteristics of N-(2-(2-(dialkylamino)ethoxy)ethyl)carboxamides. Russian Cardiology Bulletin. 2022;17(2):47‑54. (In Russ.)
https://doi.org/10.17116/Cardiobulletin20221702147

ЭндоКард
Подписка 2026 Кардиологический вестник (Russian Cardiology Bulletin)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Refralon for drug-induced cardioversion of atrial fibrillation in patients with coro­nary artery disease. Russian Cardiology Bulletin. 2024;(4-2):188-196
Modern concepts of mana­ging patients with thyrotoxic heart. Russian Journal of Preventive Medi­cine. 2024;(10):125-130
Abstract:

Heart rhythm disturbances have a special place among cardiovascular diseases and often cause sudden death and various dangerous complications. Modern antiarrhythmic drugs belonging to different classes of chemical compounds often have trivial efficacy and pro-arrhythmic action that significantly limits their use in certain clinical cases. Screening of new original compounds of N-(2-(2-(dialkylamino)ethoxy)ethyl)carboxamide class and subsequent pharmacological and toxicological analysis allowed identifying the compounds with antiarrhythmic properties and high antiarrhythmic indices. These compounds have a great practical interest for synthesis of new drugs for prevention and treatment of cardiac arrhythmias.

Keywords:

aminoamides
arrhythmia
new drugs
antiarrhythmic drugs
antiarrhythmic index
toxicological studies
pharmacological studies

Authors:

Kaldyrkaeva O.S.

National Medical Research Centre of Cardiology named after academician E.I. Chazov

Arzamastsev E.V.

National Medical Research Centre of Cardiology named after academician E.I. Chazov

Terekhova O.A.

National Medical Research Centre of Cardiology named after academician E.I. Chazov

Afanasieva E.Yu.

National Medical Research Centre of Cardiology named after academician E.I. Chazov

Levitskaya E.L.

National Medical Research Centre of Cardiology named after academician E.I. Chazov

Kydryavtseva E.V.

National Medical Research Centre of Cardiology named after academician E.I. Chazov

Polyektova V.P.

National Medical Research Centre of Cardiology named after academician E.I. Chazov

Gaisinyuk T.V.

National Medical Research Centre of Cardiology named after academician E.I. Chazov

Borisova E.Ya.

MIREA — Russian Technological University

Borisova N.Yu.

MIREA — Russian Technological University

Asilova N.Yu.

MIREA — Russian Technological University

Zubin E.M.

MIREA — Russian Technological University

Krylov A.V.

MIREA — Russian Technological University

Received:

28.03.2022

Accepted:

14.04.2022

Close metadata

References:

  1. https://www.who.int/ru/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
  2. Mironov NY, Golitsyn SP. Review of New American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Kardiologiia. 2018;58(11):94-100. (In Russ.). https://doi.org/10.18087/cardio.2018.11.10201
  3. Chazov EI, Golitsyn SP. Guideline on Heart Rhythm Disorders. M.: GEOTAR-Media; 2010. (In Russ.).
  4. Mironov NY, Yuricheva Yu.A, Vlodzyanovskiy VV, et al. Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety. Rational Pharmacotherapy in Cardiology. 2021;17(5):668-673.  https://doi.org/10.20996/1819-6446-2021-10-06
  5. Chazov EI. Editor-in-Chief’s letter to the readers. Russian Cardiology Bulletin. 2018;13(1):4. (In Russ.).
  6. Shalnova SA, Deev AD, Oganov RG. Factors influencing cardiovascular mortality in Russian population. Cardiovascular Therapy and Prevention. 2005;4(1):4-9. (In Russ.).
  7. Rukovodstvo po provedeniyu doklinicheskih issledovanij lekarstvennyh sredstv. Chast’ pervaya. M.: Grif i K;. 2012. (In Russ.).
  8. https://docs.cntd.ru/document/456026101?marker=6560IO
  9. OECD Guidelines for the Testing of Chemicals, Section 4.  https://www.oecd-ilibrary.org/environment/oecd-guidelines-for-the-testing-of-chemicals-section-4-health-effects_20745788
  10. https://www.ich.org/page/safety-guidelines
  11. https://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000083.jsp&mid=WC0b01ac0580027548 
  12. European Convention for the protection of vertebrate animals used for experimental and other scientific purposes, Strasbourg, 18 March 1986.
  13. Deichmann WB, LeBlanc TJ. Determination of the approximate lethal dose with about six animals. Journal of Industrial Hygiene and Toxicology. 1943;25:415-417. 
  14. Litchfield JT, Wilcoxon FA. simplified method of evaluating dose-effect experiments. Journal of Pharmacology and Experimental Therapeutics. 1949;96(2):99-113. 
  15. Belenkiy ML. Elements of quantitive asessment of the pharmacological effect. Leningrad: Medicine; 1963. (In Russ.).
  16. Szekeres L. Experimental models for the study of antiarrhythmic agents. Progr. mPharmacol. 1979; 2(4): 25-31. 
  17. Arzamastsev EV. The safety of drugs at the stage of screening and preclinical toxicological studies. Lab Zhyvotnye. 1991;1(2):60-64. 
  18. Randall LO, Selitto JJ. A method for measurement of analgesic activity on inflamed tissue. Archives Internationales de Pharmacodynamie et de Therapie. 1957;111(4):409-419. 
  19. Berkhin EB. Pharmacology and physiological foundation of kidneys. M.: Medicine; 1979. (In Russ.).
  20. Davidov BI. Elimination of cystamine in the organism and prolongation of its radioprotective effect. Problems of Space Biology. v. XIV. Radiobiological aspects of organism reactivity in connection with space missions. Nauka. 1971;137-158. (In Russ.).
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.